HSA Singapore SG-eCTD Version 1.1 Package Update

The Health Sciences Authority (HSA) of Singapore has released an updated package for SG-eCTD version 1.1. This update pertains to the electronic Common Technical Document submission format used for regulatory filings.

Maryland AG Sues Trump Admin Over USDA Funding Conditions

Maryland's Attorney General joined 21 other states in suing the Trump administration over new, allegedly unlawful conditions imposed on USDA funding programs. The lawsuit challenges conditions related to immigration, diversity, equity, and inclusion, which the states argue are unrelated to USDA's mission and threaten critical services for vulnerable populations.

MHRA Class 2 Medicines Recall: Hibiwash 500ml due to Microbial Contamination

The MHRA has issued a Class 2 Medicines Recall for Hibiwash 500ml manufactured by Regent Medical Limited / Mölnlycke Health Care due to microbial contamination. Specific batches are affected, and the recall is being conducted to protect public health.

Speech on Financial Stability, Regulation, and Economic Research

The Bank of Italy, in a speech at a conference on financial stability, highlighted key questions regarding deposit dynamics, unrealized losses, non-bank intermediation, and digitalization's impact on financial stability. The speech emphasized the need for economic research to adapt to the evolving financial system and inform policy choices.

WHO and Partners Launch Digital Health Wallets for ASEAN

The WHO, in partnership with the Temasek Foundation, has launched a three-year initiative to help ASEAN Member States transition from paper-based health records to digital health wallets. This program aims to strengthen national health systems and improve continuity of care by providing trusted, portable access to essential health information.

Ukraine Sanctions Update: 7 Individuals Removed

The Swiss Federal Department of Economic Affairs, Education and Research (WBF) has updated sanctions related to the situation in Ukraine. Seven individuals have been removed from Annex 8 of the relevant ordinance, with the changes taking effect on March 20, 2026.

ANSM Surveillance of Ixchiq Vaccine Adverse Effects

The French National Agency for the Safety of Medicines and Health Products (ANSM) is continuing its surveillance of adverse effects associated with the Ixchiq vaccine, used for chikungunya prevention. This notice serves to inform the public and healthcare professionals about ongoing monitoring activities.

EMA CHMP Meeting Agenda March 2026

The European Medicines Agency (EMA) has published the agenda for the Committee for Medicinal Products for Human Use (CHMP) meeting scheduled for March 23-26, 2026. The agenda outlines discussions on various medicinal products, including initial applications, oral explanations for pre-authorisation, re-examination, and post-authorisation procedures.

EMA CHMP Meeting Agenda March 2026

The European Medicines Agency (EMA) has published the agenda for the Committee for Medicinal Products for Human Use (CHMP) meeting scheduled for March 23-26, 2026. The agenda outlines 23 procedures, including annual reassessments and Periodic Safety Update Reports (PSURs), for review by the committee.

PCAOB Announces 2026 Forums for Small Business and Broker-Dealer Auditors

The PCAOB announced a series of in-person forums scheduled for 2026, aimed at auditors of small businesses and broker-dealers. These events will provide information and resources on audit quality and regulatory developments, fostering dialogue between auditors and the PCAOB.